Drug reimbursement: Indicators of inappropriate resource allocation
Open Access
- 11 November 2002
- journal article
- research article
- Published by Wiley
- Vol. 54 (5) , 528-534
- https://doi.org/10.1046/j.1365-2125.2002.01690.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Calcitonin for preventing and treating corticosteroid-induced osteoporosisCochrane Database of Systematic Reviews, 2000
- Assessment of the impact of fibrates and diet on survival and their cost-effectiveness: evidence from randomized, controlled trials in coronary heart disease and health economic evaluationsClinical Therapeutics, 1999
- Fortnightly Review: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctorsBMJ, 1996
- Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patientsBMJ, 1996
- Cost containment and health care reform: a study of the European UnionHealth Policy, 1994
- Evaluating Drugs after Their Approval for Clinical UseNew England Journal of Medicine, 1993
- Pharmaceutical prescriptions in four European countriesThe Lancet, 1993
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Prescribing in Europe--forces for change.BMJ, 1992
- Technological "Shortcuts" to Social ChangeScience, 1972